Seme Diallo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Insulin Resistance

Coronavirus Disease

Angiotensin Converting Enzyme

Monoclonal Antibody

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores, Andrew Dippel, Vaheh Oganesyan, Nydia Van Dyk, Xiaoru Chen, Erin Cantu, Rakesh Choudhary, Michal Sulikowski, Hibret Adissu, Bhavna Chawla, Swagata Kar, Chang Liu, Aiste Dijokaite-Guraliuc, Juthathip Mongkolsapaya, Saravanan Rajan, Yueh-Ming Loo, Rohini Beavon, Chris Webber, Lee-Jah Chang, Steven Thomas, Lindsay E Clegg, Huixia Zhang, Gavin R Screaton, Nora Philbin, Mark Harre, Abdulhafez Selim, Nuria Martinez-Alier, Alison Uriel, Taylor S Cohen, John L Perez, Mark T Esser, Wade Blair, Joseph R Francica
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults. Science translational medicine 16 (753) (2024)
Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores, Andrew Dippel, Vaheh Oganesyan, Nydia Van Dyk, Xiaoru Chen, Erin Cantu, Rakesh Choudhary, Michal Sulikowski, Hibret Adissu, Bhavna Chawla, Swagata Kar, Chang Liu, Aiste Dijokaite-Guraliuc, Juthathip Mongkolsapaya, Saravanan Rajan, Yueh-Ming Loo, Rohini Beavon, Chris Webber, Lee-Jah Chang, Steven Thomas, Lindsay E Clegg, Huixia Zhang, Gavin R Screaton, Nora Philbin, Mark Harre, Abdulhafez Selim, Nuria Martinez-Alier, Alison Uriel, Taylor S Cohen, John L Perez, Mark T Esser, Wade Blair, Joseph R Francica
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults. Science translational medicine 16 (753) (2024)
Yueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, Michael E Abram, Anastasia A Aksyuk, Seme Diallo, Daniel J Flores, Elizabeth J Kelly, Kuishu Ren, Richard Roque, Kim Rosenthal, Katie Streicher, Kevin M Tuffy, Nicholas J Bond, Owen Cornwell, Jerome Bouquet, Lily I Cheng, James Dunyak, Yue Huang, Anton I Rosenbaum, Venkatesh Pilla Reddy, Hanne A Elyard, Robert H Carnahan, James E Crowe, Ana I Kuehne, Andrew S Herbert, John M Dye, Helen Bright, Nicole L Kallewaard, Menelas N Pangalos, Mark T Esser
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans. Science translational medicine 14 (635) (2022)